References
- 1. Threatt J, Williamson JF, Huynh K, Davis RM, Hermayer K. Ocular disease, knowledge and technology applications in patients with diabetes. Am J Med Sci. 2013;345(4):266-270.
- 2. Bikbova G, Oshitari T, Baba T, Bikbov M, Yamamoto S. Diabetic corneal neuropathy: clinical perspectives. Clin Ophthalmol. 2018;12:981-987.
- 3. Rosenberg ME, Tervo TM, Immonen IJ, Müller LJ, Grönhagen-Riska C, Vesaluoma MH. Corneal structure and sensitivity in type 1 diabetes mellitus. Invest Ophthalmol Vis Sci. 2000;41(10):2915-2921.
- 4. Mocan MC, Durukan I, Irkec M, Orhan M. Morphologic alterations of both the stromal and subbasal nerves in the corneas of patients with diabetes. Cornea. 2006;25(7):769-773.
- 5. Edwards K, Pritchard N, Vagenas D, Russell A, Malik RA, Efron N. Utility of corneal confocal microscopy for assessing mild diabetic neuropathy: baseline findings of the LANDMark study. Clin Exp Optom. 2012;95(3):348-354.
- 6. Szalai E, Deák E, Módis L Jr, Németh G, Berta A, Nagy A, Felszeghy E, Káposzta R, Malik RA, Csutak A. Early corneal cellular and nerve fiber pathology in young patients with type 1 diabetes mellitus identified using corneal confocal microscopy. Invest Oph. Vis Sci. 2016;57(3):853-858
- 7. Kallinikos P, Berhanu M, O’Donnell C, Boulton AJ, Efron N, Malik RA. Corneal nerve tortuosity in diabetic patients with neuropathy. Invest Ophthalmol Vis Sci. 2004;45(2):418-422.
- 8. Patel DV, McGhee CN. In vivo confocal microscopy of human corneal nerves in health, in ocular and systemic disease, and following corneal surgery: a review. Br J Ophthalmol. 2009;93(7):853-860.
- 9. He JC, Bazan HE. Mapping the nerve architecture of diabetic human corneas. Ophthalmology. 2012;119(5):956-964.
- 10. Madonna R, Balistreri CR, Geng YJ, De Caterina R. Diabetic microangiopathy: Pathogenetic insights and novel therapeutic approaches. Vascul Pharmacol. 2017;90:1-7.
- 11. Bikbova G, Oshitari T, Baba T, Yamamoto S. Mechanisms of neuronal cell death in AGE-exposed retinas-research and literature review. Curr Diabetes Rev. 2017;13(3):280-288.
- 12. Kim J, Kim CS, Sohn E, Jeong IH, Kim H, Kim JS. Involvement of advanced glycation end products, oxidative stress and nuclear factor-kappaB in the development of diabetic keratopathy. Graefes Arch Clin Exp Ophthalmol. 2011;249(4):529-536.
- 13. Babizhayev MA, Strokov IA, Nosikov VV, Savel’yeva EL, Sitnikov VF, Yegorov YE, Lankin VZ. The role of oxidative stress in diabetic neuropathy: generation of free radical species in the glycation reaction and gene polymorphisms encoding antioxidant enzymes to genetic susceptibility to diabetic neuropathy in population of type I diabetic patients. Cell Biochem Biophys. 2015;71(3):1425-1443.
- 14. Yagihashi S, Mizukami H, Sugimoto K. Mechanism of diabetic neuropathy: Where are we now and where to go? J Diabetes Investig. 2011;2(1):18-32.
- 15. Leppin K, Behrendt AK, Reichard M, Stachs O, Guthoff RF, Baltrusch S, Eule JC, Vollmar B. Diabetes mellitus leads to accumulation of dendritic cells and nerve fiber damage of the subbasal nerve plexus in the Cornea. Invest Ophthalmol. Vis Sci 2014;55(6): 3603-3615.
- 16. Markoulli M, You JJ, Kim J, Duong CL, Tolentino JB, Karras J, Lum E. Corneal nerve morphology and tear film substance P in diabetes. Optom Vis Sci. 2017;94(7):726-731.
- 17. Dana MR. Corneal antigen-presenting cells: diversity, plasticity, and disguise: the Cogan lecture. Invest Ophthalmol Vis Sci. 2004;45(3):722-727; 721.
- 18. Qu JH, Li L, Tian L, Zhang XY, Thomas R, Sun XG. Epithelial changes with corneal punctate epitheliopathy in type 2 diabetes mellitus and their correlation with time to healing. BMC Ophthalmol. 2018;18(1):1.
- 19. Cai D, Zhu MF, Petroll WM, Koppaka V, Robertson DM. The impact of type 1 diabetes mellitus on corneal epithelial nerve morphology and the corneal epithelium. Am J Pathol. 2014;184(10):2662-2670.
- 20. Chang PY, Carrel H, Huang JS, Wang IJ, Hou YC, Chen WL, Wang JY, Hu FR. Decreased density of corneal basal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy. Am J Ophthalmol. 2006;142(3):488-490.
- 21. Di GH, Qi X, Zhao XW, Zhang SM, Danielson P, Zhou QJ. Corneal epithelium-derived neurotrophic factors promote nerve regeneration. Invest Ophthalmol Vis Sci. 2017;58(11):4695-4702.
- 22. Zhou QJ, Chen P, Di GH, Zhang YY, Wang Y, Qi X, Duan HY, Xie LX. Ciliary neurotrophic factor promotes the activation of corneal epithelial stem/progenitor cells and accelerates corneal epithelial wound healing. Stem Cells. 2015;33(5):1566-1576.
- 23. Park JH, Kang SS, Kim JY, Tchah H. Nerve growth factor attenuates apoptosis and inflammation in the diabetic Cornea. Invest Ophthalmol Vis Sci. 2016;57(15):6767-6775.
- 24. Morishige N, Uemura A, Morita Y, Nishida T. Promotion of corneal epithelial wound healing in diabetic rats by the fibronectin-derived peptide PHSRN. Cornea. 2017;36(12):1544-1548.
- 25. Hu JZ, Hu XY, Kan T. MiR-34c participates in diabetic corneal neuropathy via regulation of autophagy. Invest Ophthalmol Vis Sci. 2019;60(1):16-25.
- 26. Taylor HR, Kimsey RA. Corneal epithelial basement membrane changes in diabetes. Invest Ophthalmol Vis Sci. 1981;20(4):548-553.
- 27. Ljubimov AV, Huang ZS, Huang GH, Burgeson RE, Gullberg D, Miner JH, Ninomiya Y, Sado Y, Kenney MC. Human corneal epithelial basement membrane and integrin alterations in diabetes and diabetic retinopathy. J Histochem Cytochem. 1998;46(9):1033-1041.
- 28. Tomomatsu T, Takamura Y, Kubo, Akagi Y. Aldose reductase inhibitorcounteracts the attenuated adhesion of human corneal epithelial cells induced by high glucose through modulation of MMP-10 expression. Diabetes Res Clin Pract. 2009;86(1):16-23.
- 29. Takahashi H, Akiba K, Noguchi T, Ohmura T, Takahashi R, Ezure Y, Ohara K, Zieske JD. Matrix metalloproteinase activity is enhanced during corneal wound repair in high glucose condition. Curr Eye Res. 2000;21(2):608-615.
- 30. Ishida M, Yokoi N, Okuzawa J, Maeda K, Kinoshita S. Corneal autofluorescence in patients with diabetic retinopathy. Nippon Ganka Gakkai Zasshi. 1995;99(3):308-311.
- 31. Mishima S. Clinical investigations on the corneal endothelium. Ophthalmology. 1982;89(6):525-530.
- 32. Sato E, Mori F, Igarashi S, Abiko T, Takeda M, Ishiko S, Yoshida A. Corneal advanced glycation end products increase in patients with proliferative diabetic retinopathy. Diabetes Care. 2001;24(3):479-482.
- 33. Torricelli AA, Wilson SE. Cellular and extracellular matrix modulation of corneal stromal opacity. Exp Eye Res. 2014;129:151-160.
- 34. Kumar N, Pop-Busui R, Musch DC, Reed DM, Momont AC, Hussain M, Raval N, Moroi SE, Shtein R. Central corneal thickness increase due to stromal thickening with diabetic peripheral neuropathy severity. Cornea. 2018;37(9):1138-1142.
- 35. Kowalczuk L, Latour G, Bourges JL, Savoldelli M, Jeanny JC, Plamann K, Schanne-Klein MC, Behar-Cohen F. Multimodal highlighting of structural abnormalities in diabetic rat and human corneas. Transl Vis Sci Technol. 2013;2(2):3.
- 36. Zou CL, Wang SY, Huang F, Zhang YA. Advanced glycation end products and ultrastructural changes in corneas of long-term streptozotocin-induced diabetic monkeys. Cornea. 2012;31(12):1455-1459.
- 37. Priyadarsini S, Rowsey TG, Ma JX, Karamichos D. Unravelling the stromal-nerve interactions in the human diabetic Cornea. Exp Eye Res. 2017;164:22-30.
- 38. Todorovic D, Sarenac Vulovic T, Sreckovic S, Jovanovic S, Janicijevic K, Todorovic Z. Updates on the treatment of pterygium. Ser J Exp Clin Res. 2016; 17 (3): 257-261 doi: 10.1515/SJECR-2016-0012.
- 39. Saghizadeh M, Kramerov AA, Tajbakhsh J, Aoki AM, Wang C, Chai NN, Ljubimova JY, Sasaki T, Sosne G, Carlson MR, Nelson SF, Ljubimov AV. Proteinase and growth factor alterations revealed by gene microarray analysis of human diabetic corneas. Invest Ophthalm. 2005;46(10):3604-3615.
- 40. Schwarz C, Aldrich BT, Burckart KA, Schmidt GA, Zimmerman MB, Reed CR, Greiner MA, Sander EA. Descemet membrane adhesion strength is greater in diabetics with advanced disease compared to healthy donor corneas. Exp Eye Res. 2016;153:152-158.
- 41. Priyadarsini S, McKay TB, Sarker-Nag A, Allegood J, Chalfant C, Ma JX, Karamichos D. Complete metabolome and lipidome analysis reveals novel biomarkers in the human diabetic corneal stroma. Exp Eye Res. 2016;153:90-100.
- 42. Liaboe CA, Aldrich BT, Carter PC, Skeie JM, Burckart KA, Schmidt of diabetes mellitus on donor corneal endothelial cell density. Cornea. 2017;36(5):561-566.
- 43. El-Agamy A, Alsubaie S. Corneal endothelium and central corneal thickness changes in type 2 diabetes mellitus. Clin Ophthalmol. 2017;11: 481-486.
- 44. Sahu PK, Das GK, Agrawal S, Kumar S. Comparative evaluation of corneal endothelium in patients with diabetes undergoing phacoemulsification. Middle East Afr J Ophthalmol. 2017;24(2):74-80.
- 45. Storr-Paulsen A, Singh A, Jeppesen H, Norregaard JC, Thulesen J. Corneal endothelial morphology and central thickness in patients with type II diabetes mellitus. Acta Ophthalmol 2014;92(2):158-160.
- 46. Shenoy R, Khandekar R, Bialasiewicz A, Al Muniri A. Corneal endothelium in patients with diabetes mellitus: a historical cohort study. Eur J Ophthalmol. 2009;19(3):369-375.
- 47. González-Méijome JM, Jorge J, Queirós A, Peixoto-de- Matos SC,Parafita MA. Two single descriptors of endothelial polymegethism and pleomorphism. Graefes Arch Clin Exp Ophthalmol. 2010;248(8):1159-1166.
- 48. Mathew PT, David S, Thomas N. Endothelial cell loss and central corneal thickness in patients with and without diabetes after manual small incision cataract surgery. Cornea. 2011;30(4):424-428.
- 49. Kaji Y, Amano S, Usui T, Suzuki K, Tanaka S, Oshika T, Nagai R, Horiuchi S. Advanced glycation end products in Descemet’s membrane and their effect on corneal endothelial cell. Curr Eye Res. 2001;23(6):469-477.
- 50. Aldrich BT, Schlötzer-Schrehardt U, Skeie JM, Burckart KA, Schmidt GA, Reed CR, Zimmerman MB, Kruse FE, Greiner MA. Mitochondrial and morphologic alterations in native human corneal endothelial cells associated with diabetes mellitus. Invest Ophthalmol Vis Sci. 2017;58(4):2130-2138
- 51. Eghrari AO, Riazuddin SA, Gottsch JD. Overview of the cornea: structure, function, and development. Prog Mol Biol Transl Sci. 2015;134: 7-23.
- 52. Latour G, Kowalczuk L, Savoldelli M, Bourges JL, Plamann K, Behar-Cohen F, Schanne-Klein MC. Hyperglycemia- induced abnormalities in rat and human corneas: the potential of second harmonic generation microscopy. PLoS One. 2012;7(11):e48388.
- 53. Akimoto Y, Sawada H, Ohara-Imaizumi M, Nagamatsu S, Kawakami H. Change in long-spacing collagen in Descemet’s membrane of diabetic Goto-Kakizaki rats and its suppression by antidiabetic agents. Exp Diabetes Res. 2008;2008:818341.
- 54. Nubile M, Lanzini M, Miri A, Pocobelli A, Calienno R, Curcio C, Mastropasqua R, Dua HS, Mastropasqua L. In vivo confocal microscopy in diagnosis of limbal stem cell deficiency. Am J Ophthalmol. 2013;155(2):220-232.
- 55. Ueno H, Hattori T, Kumagai Y, Suzuki N, Ueno S, Takagi H.Alterations in the corneal nerve and stem/progenitor cells in diabetes: preventive effects of insulin-like growth factor-1 treatment. Int J Endocrinol. 2014;2014:312401.
- 56. Stuard WL, Titone R, Robertson DM. Tear levels of insulin- like growth factor binding protein 3 correlate with subbasal nerve plexus changes in patients with type 2 diabetes mellitus. Invest Ophthalmol Vis Sci. 2017;58(14):6105-6112.
- 57. Sarenac Vulovic T, Pavlovic S, Janicijevic K, Todorovic D, Lutovac M, Paunovic S, et al. Tear film stability in patients with pseudexfoliation. Ser J Exp Clin Res. 2018; 19 (3): 243-246. doi: 10.1515/SJECR-2017-0002.
- 58. Rocha EM, Alves M, Rios JD, Dartt DA. The aging lacrimal gland: changes in structure and function. Ocul Surf 2008;6(4):162-174.
- 59. Joussen AM, Poulaki V, Le ML, Koizumi K, Esser C, Janicki H, Schraermeyer U, Kociok N, Fauser S, Kirchhof B, Kern TS, Adamis AP. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450-1452.
- 60. Massingale ML, Li XH, Vallabhajosyula M, Chen DM, Wei Y, Asbell PA. Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea. 2009;28(9):1023-1027.
- 61. Kaufman HE. The practical detection of MMP-9 diagnoses ocular surface disease and may help prevent its complications. Cornea. 2013; 32(2):211-216.
- 62. Liu H, Sheng M, Liu Y, Wang P, Chen Y, Chen L, Wang W, Li B. Expression of SIRT1 and oxidative stress in diabetic dry eye. Int J Clin Exp Pathol. 2015;8(6):7644-7653.
- 63. Eissa IM, Khalil NM, El-Gendy HA. A controlled study on the correlation between tear film volume and tear film stability in diabetic patients. J Ophthalmol. 2016;2016:5465272.
- 64. Cousen P, Cackett P, Bennett H, Swa K, Dhillon B. Tear production and corneal sensitivity in diabetes. J Diabetes Complicat. 2007;21(6):371-373.
- 65. Ding J, Liu Y, Sullivan DA. Effects of insulin and high glucose on human meibomian gland epithelial cells. Invest Ophthalmol Vis Sci. 2015;56(13):7814-7820.
- 66. Sayin N, Kara N, Pekel G. Ocular complications of diabetes mellitus. World J Diabetes. 2015; 6(1): 92–108.